Showing results (231-240 of 527) with videos related to
Sort By:
Pageof 53
Brain : a Journal of Neurology|April 8, 2006
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementiaMirko Bibl, Brit Mollenhauer, Hermann Esselmann, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 9, 2018
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob diseaseNiels Kruse, Amanda Heslegrave, Vandana Gupta, et al.Biomarkers in Medicine|August 29, 2015
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literatureAnja Hviid Simonsen, Bea Kuiperij, Omar Mukhtar Ali El-Agnaf, et al.Neuro-Degenerative Diseases|July 12, 2007
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodiesBrit Mollenhauer, Petra Steinacker, Erik Bahn, et al.Journal of Neurochemistry|October 11, 2015
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disordersBrit Mollenhauer, Lucilla Parnetti, Irena Rektorova, et al.ACS Chemical Neuroscience|April 7, 2021
Synergistic Association between Plasma Aβ1-42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal DementiaMing-Jang Chiu, Shieh-Yueh Yang, Ta-Fu Chen, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 31, 2024
A cross-language speech model for detection of Parkinson's diseaseWee Shin Lim, Shu-I Chiu, Pei-Ling Peng, et al.Stem Cell Research|March 11, 2020
Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 geneHan-Yi Lin, Li-Kai Tsai, Yu-Che Cheng, et al.Archives of Neurology|January 12, 2005
Parkin mutations and early-onset parkinsonism in a Taiwanese cohortRuey-Meei Wu, Rebecca Bounds, Sarah Lincoln, et al.Stem Cell Research|April 13, 2019
Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 geneYu-Che Cheng, Han-I Lin, Shih-Han Syu, et al.Pageof 53